Post by
rsteve6 on Apr 18, 2017 9:02am
Speculation
I think somebody is going to buy this guy. Pharma will want to get into this industry and Emblem is probably the best value play with little risk in the sector. Sales increasing rapidly, so rapidly that production can't keep up! Oils licence on the way.
Lets wait and see
Comment by
cressco on Apr 18, 2017 10:23am
Based on the updated presentation they have somewhere around 37 million in cash...5 million in mortgage debt.
Comment by
cressco on Apr 18, 2017 12:02pm
Thank you rsteve6, these 4 rooms are part of their phase 1 and 2 medical capacity, which is mentioned in the current presentation. However rest of your quotations appears outdated. Please see the new corporate presentation. If you contact Ali from IR he will email it to you within minutes. Regards
Comment by
anmckenn on Apr 18, 2017 11:19am
its gonna be quality not quantity with these guys. It has been described as the "fine wines" of the industry and they will be able to charge a premium for that. Their pharma is gonna be what is targeted when looking at takeouts and legalization is the runway for M&A activity. News should come soon regarding new phase and she will move fast. Double digits in a day.
Comment by
cressco on Apr 18, 2017 12:08pm
Im a big fan of this project in general anmckenn and have zero doubt for the long run. Im just baffled at the math of the current supply and demand situation in the medical market. This is precisely why im assuming that medical expansion is inevitable beyond their phase 2, and they have plenty of capital to pursue this. Regards